Capricor Therapeutics, Inc. (CAPR)
USD 12.52
(-5.15%)
USD 12.52
(-5.15%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -25.59 Million | 4.91 Million | -16.8 Million | -10.05 Million | -6.82 Million | -13.86 Million |
| Net Income | -22.28 Million | -29.01 Million | -20.02 Million | -13.65 Million | -7.64 Million | -15.19 Million |
| Depreciation & Amortization | 1.06 Million | 533.13 Thousand | 245.69 Thousand | 143.89 Thousand | 171.95 Thousand | 157.65 Thousand |
| Deferred income taxes | 8.43 Billion | - | -310.25 Thousand | -325.89 Thousand | - | - |
| Stock-based compensation | 7.39 Million | 4.45 Million | 2.96 Million | 1.95 Million | 700.98 Thousand | 1.72 Million |
| Change in working capital | -11.75 Million | 28.74 Million | 182.33 Thousand | 1.5 Million | -55.34 Thousand | -554.58 Thousand |
| Other non-cash items | -8.43 Billion | 196 Thousand | 129.72 Thousand | 325.89 Thousand | 2720.00 | 2.31 Million |
| Investing Cash Flow | 5.1 Million | -35.07 Million | -1.19 Million | 5.43 Million | -3 Million | 4.67 Million |
| Investments in PPE | -2.04 Million | -3.35 Million | -1.19 Million | -547.6 Thousand | - | -316.48 Thousand |
| Acquisitions | 735.87 Million | 1.35 Billion | - | -5.98 Million | - | - |
| Investment purchases | -97.44 Million | -114.21 Million | - | -6.13 Million | -6 Million | -18.01 Million |
| Sales/Maturities of investments | 104.59 Million | 82.5 Million | - | 12.11 Million | 3 Million | 23 Million |
| Other Investing Activities | -735.87 Million | -1.35 Billion | - | 5.98 Million | -3 Million | 4.98 Million |
| Financing Cash Flow | 25.57 Million | 4.87 Million | 20.22 Million | 33.38 Million | 9.17 Million | 6.85 Million |
| Debt repayment | - | -1359.49 | - | -318.16 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -193.00 | - |
| Common Stock Issuance | 25.57 Million | 4.8 Million | 20.22 Million | 27.34 Million | 9.17 Million | 6.71 Million |
| Other Financing Activities | 64.6 Million | 71.66 Thousand | 20.22 Million | 6.35 Million | 3222.00 | 139.14 Thousand |
| Accounts receivables | -9.82 Million | -155.83 | -391.75 Million | 87.96 Million | 116.9 Million | 139.7 Million |
| Accounts payables | 1.32 Million | 1.2 Million | 991.16 Thousand | 1.82 Billion | -273.17 Million | -415.45 Thousand |
| Inventory | - | 0.83 | 391.75 Million | -1.91 Billion | 156.27 Million | -139.79 Million |
| Other working capital | -3.25 Million | 27.54 Million | -808.83 Thousand | 1.5 Million | -55.34 Thousand | -55.81 Thousand |
| Cash at beginning of period | 9.6 Million | 34.88 Million | 32.66 Million | 3.89 Million | 4.54 Million | 6.88 Million |
| Cash at end of period | 14.69 Million | 9.6 Million | 34.88 Million | 32.66 Million | 3.89 Million | 4.54 Million |
| Capital Expenditure | -2.04 Million | -3.35 Million | -1.19 Million | -547.6 Thousand | - | -316.48 Thousand |
| Effect of forex changes on cash | 5.08 Billion | - | - | - | - | - |
| Net cash flow / Change in cash | 5.09 Million | -25.28 Million | 2.21 Million | 28.76 Million | -645.76 Thousand | -2.33 Million |
| Free Cash Flow | -27.64 Million | 1.55 Million | -18 Million | -10.6 Million | -6.82 Million | -14.17 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -10.99 Million | -9.79 Million | -22.28 Million | -762.08 Thousand | -6.39 Million | -7.36 Million |
| Depreciation & Amortization | 356.93 Thousand | 331.4 Thousand | 1.06 Million | 307.6 Thousand | 276.47 Thousand | 254.7 Thousand |
| Deferred income taxes | - | - | 8.43 Billion | -12.84 Million | 5388.00 | - |
| Stock-based compensation | 2.15 Million | 3.26 Million | 7.39 Million | 1.86 Million | 1.71 Million | 1.61 Million |
| Change in working capital | -3.78 Million | 4.93 Million | -11.75 Million | -12.99 Million | -4.4 Million | -3.91 Million |
| Other non-cash items | 2.93 Million | -6.08 Million | -8.43 Billion | 12.83 Million | -1017.00 | -6452.00 |
| Investing Cash Flow | 14.69 Million | -9.5 Million | 5.1 Million | -5.86 Million | 7.72 Million | 6.46 Million |
| Investments in PPE | -80.9 Thousand | -664.31 Thousand | -2.04 Million | -729.22 Thousand | -631.75 Thousand | -233.44 Thousand |
| Acquisitions | - | - | 735.87 Million | 5.13 Million | -8.35 Million | -6.69 Million |
| Investment purchases | -16.07 Million | -33.21 Million | -97.44 Million | -24.77 Million | -19.8 Million | -18.06 Million |
| Sales/Maturities of investments | 30.84 Million | 24.37 Million | 104.59 Million | 19.64 Million | 28.15 Million | 24.75 Million |
| Other Investing Activities | 14.77 Million | -55.72 Million | -735.87 Million | -5.13 Million | 8.35 Million | 6.69 Million |
| Financing Cash Flow | 2.06 Million | 2.29 Million | 25.57 Million | 23.16 Million | 221.08 Thousand | 2.18 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.06 Million | 2.29 Million | 25.57 Million | 23.16 Million | 221.08 Thousand | 2.18 Million |
| Other Financing Activities | 2.06 Million | 2.29 Million | 64.6 Million | 23.16 Million | 221.08 Thousand | 2.18 Million |
| Accounts receivables | -975.00 | 10 Million | -9.82 Million | -9.82 Million | - | - |
| Accounts payables | -78.72 Thousand | -1584.00 | 1.32 Million | -541.7 Thousand | 1.65 Million | -291.92 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -3.7 Million | -5.06 Million | -3.25 Million | -2.62 Million | -6.06 Million | -3.62 Million |
| Cash at beginning of period | 6.21 Million | 14.69 Million | 9.6 Million | 8.98 Million | 9.83 Million | 10.6 Million |
| Cash at end of period | 10.68 Million | 6.21 Million | 14.69 Million | 14.69 Million | 8.98 Million | 9.83 Million |
| Capital Expenditure | -80.9 Thousand | -664.31 Thousand | -2.04 Million | -729.22 Thousand | -631.75 Thousand | -233.44 Thousand |
| Effect of forex changes on cash | - | - | 5.08 Billion | - | - | - |
| Net cash flow / Change in cash | 4.47 Million | -8.48 Million | 5.09 Million | 5.71 Million | -852.46 Thousand | -768.39 Thousand |
| Free Cash Flow | -12.36 Million | -1.93 Million | -27.64 Million | -12.32 Million | -9.42 Million | -9.65 Million |
HUMANSOFT
DECCAN
BPL
RAMCOIND
603077
PREMIERPOL